Infections in Thalassemia and Hemoglobinopathies: Focus on Therapy-Related Complications
Author Information
Author(s): Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
Primary Institution: Università Cattolica del Sacro Cuore
Hypothesis
What are the mechanisms that predispose patients with thalassemia and sickle cell disease to infections?
Conclusion
Infections remain a significant risk for patients with thalassemia and sickle cell disease, influenced by both the diseases themselves and their treatments.
Supporting Evidence
- Infections are the second leading cause of death in thalassemia patients in Italy.
- Transfusion therapy has improved outcomes but also increases infection risk.
- Sickle cell disease patients show variable infection-related mortality rates.
- Immunological abnormalities in thalassemia and sickle cell disease contribute to increased infection risk.
- Preventive measures like vaccinations and penicillin prophylaxis are crucial for splenectomized patients.
Takeaway
Kids with thalassemia and sickle cell disease can get really sick from infections, and doctors need to be careful about how they treat them to keep them safe.
Methodology
The review compares and contrasts the mechanisms of infection risk in thalassemia and sickle cell disease, focusing on immune dysfunction and therapy-related complications.
Potential Biases
Potential biases may arise from the selection of studies and the interpretation of data across different regions and populations.
Limitations
The review is based on existing literature and may not cover all recent findings or variations in different populations.
Participant Demographics
The review discusses findings from various studies across different countries, including Italy, Greece, Taiwan, and the USA.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 8.2–14.4
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website